ReviewBritish journal of clinical pharmacology2020

Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines.

Jane Moseley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.